Back
Aligos Therapeutics Stock Predictions
Former Zillow exec targets $1.3T marke
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Sell
41
ALGS
Aligos Therapeutics
Last Price:
$7.69
Seasonality Move:
-9.63%
7 Day Trial
ALL ACCESS PASS
$
7
How to hack a $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compaAligos Therapeutics Stock Forecast
-
Over the next 52 weeks, Aligos Therapeutics has on average historically fallen by 45.7% based on the past 4 years of stock performance.
-
Aligos Therapeutics has fallen lower in 4 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
-
Is Aligos Therapeutics Stock Undervalued?The current Aligos Therapeutics [ALGS] share price is $7.55. The Score for ALGS is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
ALGS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Aligos Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Aligos Therapeutics has on average historically fallen by 45.7% based on the past 4 years of stock performance.
Aligos Therapeutics Stock Rating
Sell
41
Aligos Therapeutics (ALGS)
is a Sell
Is Aligos Therapeutics overpriced?
-
Aligos Therapeutics has fallen lower in 4 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
Aligos Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
aligos.com
52-Week Data
52-Week High:
46.80
52-Week Low:
3.76
Prediction Charts
Market Cap:
46.2M
Price in USD:
7.55
Volume:
152.9K
Beta:
2.70
Technical Analysis
SMA50:
5.79
SMA100:
10.83
SMA200:
15.57
52-Wk Change:
-27.42%
Stock Predictions
-
Is Aligos Therapeutics stock public?Yes, Aligos Therapeutics is a publicly traded company.
-
What is the Aligos Therapeutics stock quote today?The Aligos Therapeutics stock price is 7.55 USD today.
-
How to buy Aligos Therapeutics stock online?You can buy Aligos Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jun-2 | 5.26 | 5.25 | 5.56 | 5.12 |
| Jun-3 | 5.28 | 5.95 | 5.95 | 5.27 |
| Jun-4 | 5.87 | 6.29 | 6.53 | 5.76 |
| Jun-5 | 6.25 | 6.05 | 6.54 | 5.91 |
| Jun-6 | 6.24 | 7.20 | 7.46 | 6.18 |
| Jun-9 | 7.54 | 7.19 | 7.78 | 6.90 |
| Jun-10 | 7.35 | 7.30 | 7.79 | 6.90 |
| Jun-11 | 7.52 | 7.89 | 8.16 | 7.36 |
| Jun-12 | 7.80 | 8.03 | 8.35 | 7.54 |
| Jun-13 | 7.69 | 7.71 | 8.36 | 7.59 |
| Jun-16 | 7.90 | 8.05 | 8.28 | 7.78 |
| Jun-17 | 8.00 | 7.53 | 8.06 | 7.50 |
| Jun-18 | 7.58 | 8.37 | 8.49 | 7.43 |
| Jun-20 | 8.50 | 7.55 | 8.50 | 7.55 |
Aligos Therapeutics Earnings
Aligos Therapeutics Earnings Report: Per Share Aligos Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Aligos Therapeutics Forecast Revenue Growth
Aligos Therapeutics Stock Analysis: Historical quarterly revenues per share for Aligos Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $1.36 per share, a decrease next quarter of $0.07 per share, an increase this year of $3.67 per share, and a decrease next year of $1.69 per share.
* Aligos Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.